The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Molecular mechanisms for enhanced DNA vaccine immunogenicity
Open accessAbstract
In the two decades since their initial discovery, DNA vaccines technologies have come a long way. Unfortunately, when applied to human subjects inadequate immunogenicity is still the biggest challenge for practical DNA vaccine use. Many different strategies have been tested in preclinical models to address this problem, including novel plasmid vectors and codon optimization to enhance antigen expression, new gene transfection systems or electroporation to increase delivery efficiency, protein or live virus vector boosting regimens to maximise immune stimulation, and formulation of DNA vaccines with traditional or molecular adjuvants. Better understanding of the mechanisms of action of DNA vaccines has also enabled better use of the intrinsic host response to DNA to improve vaccine immunogenicity. This review summarizes recent advances in DNA vaccine technologies and related intracellular events and how these might impact on future directions of DNA vaccine development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 1×
“DNA sequences containing unmethylated cytosine-guanine (CpG) motifs leading to activation of MyD88dependent signaling pathways.[10] CpG motifs are rare in mammalian genomes, in which they are gener-”
BackgroundCyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Sun, L., Wu, J., Du, F., Chen, X., & Chen, Z. J. (2013) · Science · doi:10.1126/science.1232458 · Cited by 4,996
Direct Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173 · cited 1×
“expressing chloramphenicol acetyltransferase, luciferase and -galactosidase into mouse skeletal muscle.[5] The expression of reporter genes in vivo was readily detect-”
BackgroundHeterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., Friedman, A., et al. (1993) · Science · doi:10.1126/science.8456302 · Cited by 2,318
Cancer immunotherapy via dendritic cells
Palucka, K., & Banchereau, J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3258 · Cited by 2,049
DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response
Takaoka, A., Wang, Z., Choi, M. K., Yanai, H., Negishi, H., Ban, T., Lu, Y., Miyagishi, M., Kodama, T., Honda, K., et al. (2007) · Nature · doi:10.1038/nature06013 · Cited by 1,715
IFI16 is an innate immune sensor for intracellular DNA
Unterholzner, L., Keating, S. E., Baran, M., Horan, K. A., Jensen, S. B., Sharma, S., Sirois, C. M., Jin, T., Latz, E., Xiao, T. S., et al. (2010) · Nature Immunology · doi:10.1038/ni.1932 · Cited by 1,643
Genetic immunization is a simple method for eliciting an immune response
Tang, D.-C., DeVit, M., & Johnston, S. A. (1992) · Nature · doi:10.1038/356152a0 · Cited by 1,498
Gao, P., Ascano, M., Wu, Y., Barchet, W., Gaffney, B. L., Zillinger, T., Serganov, A. A., Liu, Y., Jones, R. A., Hartmann, G., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.046 · Cited by 1,101
DNA vaccines: ready for prime time?
Kutzler, M. A., & Weiner, D. B. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2432 · Cited by 1,077
Vaccine adjuvants: Current state and future trends
Petrovsky, N., & Aguilar, J. C. (2004) · Immunology & Cell Biology · doi:10.1111/j.0818-9641.2004.01272.x · Cited by 1,005
Self-citationStructure-based programming of lymph-node targeting in molecular vaccines
Liu, H., Moynihan, K. D., Zheng, Y., Szeto, G. L., Li, A. V., Huang, B., Van Egeren, D. S., Park, C., & Irvine, D. J. (2014) · Nature · doi:10.1038/nature12978 · Cited by 943
Barouch, D. H., Santra, S., Schmitz, J. E., Kuroda, M. J., Fu, T.-M., Wagner, W., Bilska, M., Craiu, A., Zheng, X. X., Krivulka, G. R., et al. (2000) · Science · doi:10.1126/science.290.5491.486 · Cited by 881
The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells
Zhang, Z., Yuan, B., Bao, M., Lu, N., Kim, T., & Liu, Y.-J. (2011) · Nature Immunology · doi:10.1038/ni.2091 · Cited by 877
Systems biology of vaccination for seasonal influenza in humans
Nakaya, H. I., Wrammert, J., Lee, E. K., Racioppi, L., Marie-Kunze, S., Haining, W. N., Means, A. R., Kasturi, S. P., Khan, N., Li, G.-M., et al. (2011) · Nature Immunology · doi:10.1038/ni.2067 · Cited by 809
The AIM2 inflammasome is critical for innate immunity to Francisella tularensis
Fernandes-Alnemri, T., Yu, J.-W., Juliana, C., Solorzano, L., Kang, S., Wu, J., Datta, P., McCormick, M., Huang, L., McDermott, E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1859 · Cited by 732
TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines
Ishii, K. J., Kawagoe, T., Koyama, S., Matsui, K., Kumar, H., Kawai, T., Uematsu, S., Takeuchi, O., Takeshita, F., Coban, C., et al. (2008) · Nature · doi:10.1038/nature06537 · Cited by 628
DNA released from dying host cells mediates aluminum adjuvant activity
Marichal, T., Ohata, K., Bedoret, D., Mesnil, C., Sabatel, C., Kobiyama, K., Lekeux, P., Coban, C., Akira, S., Ishii, K. J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2403 · Cited by 535
Liposomes as vaccine delivery systems: a review of the recent advances
Schwendener, R. A. (2014) · Therapeutic Advances in Vaccines · doi:10.1177/2051013614541440 · Cited by 525
DNA vaccines: an historical perspective and view to the future
Liu, M. A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00980.x · Cited by 468
Manthorpe, M., Cornefert-Jensen, F., Hartikka, J., Felgner, J., Rundell, A., Margalith, M., & Dwarki, V. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.4-419 · Cited by 432
Robinson, H. L., Hunt, L. A., & Webster, R. G. (1993) · Vaccine · doi:10.1016/0264-410x(93)90385-b · Cited by 428
Parvatiyar, K., Zhang, Z., Teles, R. M., Ouyang, S., Jiang, Y., Iyer, S. S., Zaver, S. A., Schenk, M., Zeng, S., Zhong, W., et al. (2012) · Nature Immunology · doi:10.1038/ni.2460 · Cited by 406
TLR13 Recognizes Bacterial 23 S rRNA Devoid of Erythromycin Resistance–Forming Modification
Oldenburg, M., Krüger, A., Ferstl, R., Kaufmann, A., Nees, G., Sigmund, A., Bathke, B., Lauterbach, H., Suter, M., Dreher, S., et al. (2012) · Science · doi:10.1126/science.1220363 · Cited by 405 · cited 1×
“[63] TLR3 and TLR9 recognize dsRNA and ssDNA, respectively, and their ligands have been shown to act as molecular adjuvants.”
BackgroundDNA-PK is a DNA sensor for IRF-3-dependent innate immunity
Ferguson, B. J., Mansur, D. S., Peters, N. E., Ren, H., & Smith, G. L. (2012) · eLife · doi:10.7554/elife.00047 · Cited by 404
Kondo, T., Kobayashi, J., Saitoh, T., Maruyama, K., Ishii, K. J., Barber, G. N., Komatsu, K., Akira, S., & Kawai, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222694110 · Cited by 345
A critical analysis of codon optimization in human therapeutics
Mauro, V. P., & Chappell, S. A. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.09.003 · Cited by 343
A robust system for production of minicircle DNA vectors
Kay, M. A., He, C.-Y., & Chen, Z.-Y. (2010) · Nature Biotechnology · doi:10.1038/nbt.1708 · Cited by 329
Cheng, L., Ziegelhoffer, P. R., & Yang, N. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4455 · Cited by 329
Technologies for enhanced efficacy of DNA vaccines
Saade, F., & Petrovsky, N. (2012) · Expert Review of Vaccines · doi:10.1586/erv.11.188 · Cited by 309
Self-citationRNAi and small interfering RNAs in human disease therapeutic applications
Lares, M. R., Rossi, J. J., & Ouellet, D. L. (2010) · Trends in biotechnology · doi:10.1016/j.tibtech.2010.07.009 · Cited by 277
Geissler, M., Gesien, A., Tokushige, K., & Wands, J. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.3.1231 · Cited by 249
Lahoud, M. H., Ahmet, F., Kitsoulis, S., Wan, S. S., Vremec, D., Lee, C.-N., Phipson, B., Shi, W., Smyth, G. K., Lew, A. M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101176 · Cited by 227
Kalams, S. A., Parker, S. D., Elizaga, M., Metch, B., Edupuganti, S., Hural, J., De Rosa, S., Carter, D. K., Rybczyk, K., Frank, I., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit236 · Cited by 196
Bivas-Benita, M., van Meijgaarden, K. E., Franken, K. L. M. C., Junginger, H. E., Borchard, G., Ottenhoff, T. H. M., & Geluk, A. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.09.044 · Cited by 195
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
Ledgerwood, J. E., Wei, C.-J., Hu, Z., Gordon, I. J., Enama, M. E., Hendel, C. S., McTamney, P. M., Pearce, M. B., Yassine, H. M., Boyington, J. C., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70240-7 · Cited by 188
Chen, X., Fernando, G. J. P., Crichton, M. L., Flaim, C., Yukiko, S. R., Fairmaid, E. J., Corbett, H. J., Primiero, C. A., Ansaldo, A. B., Frazer, I. H., et al. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.026 · Cited by 180
Zhang, Y., Yeruva, L., Marinov, A. D., Prantner, D., Wyrick, P. B., Lupashin, V. V., & Nagarajan, U. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302718 · Cited by 178
DNA vaccines: developing new strategies to enhance immune responses
Abdulhaqq, S. A., & Weiner, D. B. (2008) · Immunologic Research · doi:10.1007/s12026-008-8076-3 · Cited by 167
Innate Immunity: Cytoplasmic DNA Sensing by the AIM2 Inflammasome
Schroder, K., Muruve, D. A., & Tschopp, J. (2009) · Current Biology · doi:10.1016/j.cub.2009.02.011 · Cited by 151
Chuang, I., Sedegah, M., Cicatelli, S., Spring, M., Polhemus, M. E., Tamminga, C., Patterson, N. B., Guerrero, M. L., Bennett, J. W., McGrath, S. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055571 · Cited by 148
Barouch, D. H., Santra, S., Steenbeke, T. D., Zheng, X. X., Perry, H. C., Davies, M.-E., Freed, D. C., Craiu, A., Strom, T. B., Shiver, J. W., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1875 · Cited by 146
Enhancement of DNA vaccine potency using conventional aluminum adjuvants
Ulmer, J. B., DeWitt, C. M., Chastain, M. A., Friedman, A., Donnelly, J., McClements, W. L., Caulfield, M. J., Bohannon, K. E., Volkin, D. B., & Evans, R. K. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00151-6 · Cited by 145
Churchyard, G., Morgan, C. A., Adams, E. M., Hural, J., Graham, B. S., Moodie, Z., Grove, D., Gray, G., Bekker, L., McElrath, M. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021225 · Cited by 142
Targeting Skin Dendritic Cells to Improve Intradermal Vaccination
Romani, N., Flacher, V., Tripp, C. H., Sparber, F., Ebner, S., & Stoitzner, P. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2010_118 · Cited by 140
Uchijima, M., Yoshida, A., Nagata, T., & Koide, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5594 · Cited by 132
A Sendai Virus-Derived RNA Agonist of RIG-I as a Virus Vaccine Adjuvant
Martínez‐Gil, L., Goff, P. H., Hai, R., García‐Sastre, A., Shaw, M. L., & Palese, P. (2012) · Journal of Virology · doi:10.1128/jvi.02338-12 · Cited by 127
Ledgerwood, J. E., Zephir, K., Hu, Z., Wei, C.-J., Chang, L., Enama, M. E., Hendel, C. S., Sitar, S., Bailer, R. T., Koup, R. A., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit180 · Cited by 123
Jaoko, W. G., Karita, E., Kayitenkore, K., Omosa-Manyonyi, G., Allen, S. A., Than, S., Adams, E. M., Graham, B. S., Koup, R. A., Bailer, R. T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012873 · Cited by 121
Moore, A., Kong, W., Chakrabarti, B. K., & Nabel, G. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.1.243-250.2002 · Cited by 120
Wang, S., Farfán-Arribas, D. J., Shen, S., Chou, T.-H. W., Hirsch, A., He, F., & Lu, S. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.08.023 · Cited by 118
Bivas‐Benita, M., Lin, M. Y., Bal, S. M., van Meijgaarden, K. E., Franken, K. L. M. C., Friggen, A. H., Junginger, H. E., Borchard, G., Klein, M. R., & Ottenhoff, T. H. M. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.033 · Cited by 118
Faurez, F., Dory, D., Moigne, V. L., Gravier, R., & Jestin, A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.03.040 · Cited by 113
Yang, S.-H., Lee, C.-G., Park, S.-H., Im, S.-J., Kim, Y.-M., Son, J.-M., Wang, J.-S., Yoon, S.-K., Song, M.-K., Ambrozaitis, A., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302751 · Cited by 111
Pradhan, P., Qin, H., Leleux, J. A., Gwak, D., Sakamaki, I., Kwak, L. W., & Roy, K. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.039 · Cited by 111
Vaccinomics and a New Paradigm for the Development of Preventive Vaccines Against Viral Infections
Poland, G. A., Ovsyannikova, I. G., Kennedy, R. B., Haralambieva, I. H., & Jacobson, R. M. (2011) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2011.0032 · Cited by 105
Osborn, M. J., McElmurry, R. T., Lees, C. J., DeFeo, A. P., Chen, Z.-Y., Kay, M. A., Naldini, L., Freeman, G. J., Tolar, J., & Blazar, B. R. (2010) · Molecular Therapy · doi:10.1038/mt.2010.249 · Cited by 103
Fossum, E., Grødeland, G., Terhorst‐Molawi, D., Tveita, A. A., Vikse, E. L., Mjaaland, S., Henri, S., MALISSEN, B., & Bogen, B. (2014) · European Journal of Immunology · doi:10.1002/eji.201445080 · Cited by 103
Kim, J. J., Simbiri, K. A., Sin, J., Dang, K., Oh, J., Dentchev, T., Lee, D. C., Nottingham, L. K., Chalian, A. A., McCallus, D. E., et al. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099314441 · Cited by 103
TLR9−/− and TLR9+/+ mice display similar immune responses to a DNA vaccine
Babiuk, S., Mookherjee, N., Pontarollo, R. A., Griebel, P., den Hurk, S. V. D. L., Hecker, R., & Babiuk, L. A. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01938.x · Cited by 99
Saiga, H., Nieuwenhuizen, N. E., Gengenbacher, M., Koehler, A., Schuerer, S., Moura‐Alves, P., Wagner, I., Mollenkopf, H., Dorhoi, A., & Kaufmann, S. H. E. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu675 · Cited by 95
Rajapaksa, A. E., Ho, J. J., Qi, A., Bischof, R. J., Nguyen, T., Tate, M. D., Piedrafita, D. M., McIntosh, M. P., Yeo, L. Y., Meeusen, E. N. T., et al. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-60 · Cited by 92
Graham, B. S., Enama, M. E., Nason, M., Gordon, I. J., Peel, S. A., Ledgerwood, J. E., Plummer, S. A., Mascola, J. R., Bailer, R. T., Roederer, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059340 · Cited by 89
TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines
Tudor, D., Dubuquoy, C., Gaboriau‐Routhiau, V., Lefèvre, F., Charley, B., & Riffault, S. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.09.001 · Cited by 88
Electroporation-enhanced delivery of nucleic acid vaccines
Broderick, K. E., & Humeau, L. M. P. F. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2015.990890 · Cited by 85
DNA vaccines, electroporation and their applications in cancer treatment
Lee, S.-H., Danishmalik, S. N., & Sin, J. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1035502 · Cited by 84
Coexpressed RIG-I Agonist Enhances Humoral Immune Response to Influenza Virus DNA Vaccine
Luke, J., Simon, G. G., Söderholm, J., Errett, J., August, J., Gale, M., Hodgson, C. P., & Williams, J. A. (2010) · Journal of Virology · doi:10.1128/jvi.01250-10 · Cited by 83
Pulmonary DNA vaccination: Concepts, possibilities and perspectives
Bivas‐Benita, M., Ottenhoff, T. H. M., Junginger, H. E., & Borchard, G. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.05.028 · Cited by 79
Corbett, A. J., Caminschi, I., McKenzie, B. S., Brady, J. L., Wright, M. D., Mottram, P. L., Hogarth, P. M., Hodder, A. N., Zhan, Y., Tarlinton, D. M., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200526100 · Cited by 76
Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes
Kim, J. J., Nottingham, L. K., Wilson, D. M., Bagarazzi, M. L., Tsai, A., Morrison, L. D., Javadian, A., Chalian, A. A., Agadjanyan, M. G., & Weiner, D. B. (1998) · Vaccine · doi:10.1016/s0264-410x(98)00177-7 · Cited by 74
PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice
Zhou, J., Cheung, A. K. L., Tan, Z., Wang, H., Yu, W., Du, Y., Kang, Y., Lu, X., Liu, L., Yuen, K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64704 · Cited by 73
IFI16: At the Interphase between Innate DNA Sensing and Genome Regulation
Jakobsen, M. R., & Paludan, S. R. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.06.004 · Cited by 72
Microneedles: an innovative platform for gene delivery
McCaffrey, J., Donnelly, R. F., & McCarthy, H. O. (2015) · Drug Delivery and Translational Research · doi:10.1007/s13346-015-0243-1 · Cited by 72
Liu, J., Wu, J., Wang, B., Zeng, S., Qi, F., Lu, C., Kimura, Y., & Liu, B. (2013) · Journal of Medical Virology · doi:10.1002/jmv.23768 · Cited by 72
Systems biological approaches to measure and understand vaccine immunity in humans
Li, S., Nakaya, H. I., Kazmin, D. A., Oh, J. Z., & Pulendran, B. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.05.003 · Cited by 69
Li, J., Valentin, A., Kulkarni, V., Rosati, M., Beach, R. K., Alicea, C., Hannaman, D., Reed, S. G., Felber, B. K., & Pavlakis, G. N. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.04.037 · Cited by 68
Cristillo, A. D., Ferrari, M. G., Hudacik, L., Lewis, B., Galmin, L., Bowen, W. S., Thompson, D. J. S., Petrovsky, N., Markham, P. D., & Pal, R. (2010) · Journal of General Virology · doi:10.1099/vir.0.023242-0 · Cited by 68
Self-citationPearson, F. E., McNeilly, C. L., Crichton, M. L., Primiero, C., Yukiko, S. R., Fernando, G. J. P., Chen, X., Gilbert, S. C., Hill, A. V. S., & Kendall, M. A. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067888 · Cited by 68
Improving DNA Vaccine Performance Through Vector Design
Williams, J. (2014) · Current Gene Therapy · doi:10.2174/156652321403140819122538 · Cited by 67
SwiftLib: rapid degenerate-codon-library optimization through dynamic programming
Jacobs, T. M., Yumerefendi, H., Kuhlman, B. A., & Leaver‐Fay, A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1323 · Cited by 64
Rosa, S. C. D., Thomas, E. P., Bui, J. K., Huang, Y., deCamp, A. C., Morgan, C. A., Kalams, S. A., Tomaras, G. D., Akondy, R. S., Ahmed, R., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101421 · Cited by 64
Helicase proteins DHX29 and RIG-I cosense cytosolic nucleic acids in the human airway system
Sugimoto, N., Mitoma, H., Kim, T. I., Hanabuchi, S., & Liu, Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400139111 · Cited by 63
Lladser, Á., Mougiakakos, D., Tufvesson, H., Ligtenberg, M. A., Quest, A. F. G., Kiessling, R. W., & Ljungberg, K. (2010) · Molecular Therapy · doi:10.1038/mt.2010.268 · Cited by 62
Minicircle DNA is Superior to Plasmid DNA in Eliciting Antigen-specific CD8+ T-cell Responses
Dietz, W., Skinner, N., Hamilton, S. E., Jund, M. D., Heitfeld, S. M., Litterman, A. J., Hwu, P., Chen, Z.-Y., Salazar, A. Μ., Ohlfest, J. R., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.85 · Cited by 62
Khurana, S., Wu, J., Dimitrova, M., King, L. R., Manischewitz, J. F., Graham, B. S., Ledgerwood, J. E., & Golding, H. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit178 · Cited by 58
A Mini-intronic Plasmid (MIP): A Novel Robust Transgene Expression Vector In Vivo and In Vitro
Lu, J., Zhang, F., & Kay, M. A. (2013) · Molecular Therapy · doi:10.1038/mt.2013.33 · Cited by 57
Cationic submicron emulsions for pulmonary DNA immunization
Bivas‐Benita, M., Oudshoorn, M., Romeijn, S. G., et al. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.008 · Cited by 57
Identification of Aim2 as a Sensor for DNA Vaccines
Suschak, J. J., Wang, S., Fitzgerald, K. A., & Lu, S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1402530 · Cited by 55
Meerak, J., Wanichwecharungruang, S. P., & Palaga, T. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.11.075 · Cited by 54
Fournillier, A., Frelin, L., Jacquier, E., Ahlén, G., Braß, A., Gerossier, E., Holmström, F., Broderick, K. E., Sardesai, N. Y., Bonnefoy, J., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit267 · Cited by 53
Cervantes-Villagrana, A. R., Hernández‐Pando, R., Biragyn, A., Castañeda‐Delgado, J. E., Bodogai, M., Martínez‐Fierro, M. L., Sada, E., Trujillo, V., Enciso‐Moreno, J. A., & Rivas-Santiago, B. T. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.11.042 · Cited by 52
Li, Z.-Y., Chen, J., Petersen, E., Zhou, D., Huang, S., Song, H., & Zhu, X. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.03.042 · Cited by 52
Nemunaitis, J. J., Barve, M. A., Orr, D. W., Kuhn, J. A., Magee, M., Lamont, J., Bedell, C., Wallraven, G., Pappen, B. O., Roth, A., et al. (2014) · Oncology · doi:10.1159/000360993 · Cited by 51
Nucleic acid sensing by T cells initiates Th2 cell differentiation
Imanishi, T., Ishihara, C., Badr, M. E. S. G., Hashimoto, A. S., Kimura, Y., Kawai, T., Takeuchi, O., Ishii, K. J., Taniguchi, S., Noda, T., et al. (2014) · Nature Communications · doi:10.1038/ncomms4566 · Cited by 50
The Top Five “Game Changers” in Vaccinology: Toward Rational and Directed Vaccine Development
Kennedy, R. B., & Poland, G. A. (2011) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2011.0012 · Cited by 48
Rottembourg, D., Filippi, C. M., Bresson, D., Ehrhardt, K., Estes, E. A., Oldham, J. E., & von Herrath, M. G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0803935 · Cited by 47
Wang, Q., Jiang, W., Chen, Y., Liu, P., Sheng, C., Chen, S., Zhang, H., Pan, C., Gao, S., & Huang, W. (2013) · Journal of Virology · doi:10.1128/jvi.02757-13 · Cited by 46
Cao, J., Jin, Y., Li, W., Zhang, B., He, Y., Liu, H., Xia, N., Wei, H., & Yan, J. (2013) · BMC Immunology · doi:10.1186/1471-2172-14-39 · Cited by 45
Hansen, J. U., Lindenstrøm, T., Lindberg-Levin, J., Aagaard, C., Andersen, P. L., & Agger, E. M. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1156-6 · Cited by 45
Lü, H., Xu, X.-F., Gao, N., Fan, D., Wang, J., & An, J. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.11.007 · Cited by 45
Koblin, B. A., Casapía, M., Morgan, C. A., Li, Q., Wang, Z. M., Defawe, O., Baden, L. R., Goepfert, P., Tomaras, G. D., Montefiori, D. C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024517 · Cited by 43
Karkada, M., Weir, G. M., Quinton, T., Fuentes-Ortega, A., & Mansour, M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.07.025 · Cited by 42
Nilsson, C., Hejdeman, B., Godoy‐Ramirez, K., Tecleab, T., Scarlatti, G., Bråve, A., Earl, P. L., Stout, R. R., Robb, M. L., Shattock, R. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131748 · Cited by 41
Solving vaccine mysteries: a systems biology perspective
Trautmann, L., & Sékaly, R. (2011) · Nature Immunology · doi:10.1038/ni.2078 · Cited by 40
Mann, J. F. S., McKay, P. F., Arokiasamy, S., Patel, R. K., Klein, K., & Shattock, R. J. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.06.004 · Cited by 39
Jiang, M., Yao, J., & Feng, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096609 · Cited by 38
Chen, J., Li, Z.-Y., Huang, S., Petersen, E., Song, H., Zhou, D., & Zhu, X. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-487 · Cited by 37
Kataoka, K., Fujihashi, K., Oma, K., Fukuyama, Y., Hollingshead, S. K., Sekine, S., Kawabata, S., Ito, H., Briles, D. E., & Oishi, K. (2011) · Infection and Immunity · doi:10.1128/iai.01360-10 · Cited by 36
Trollet, C., Pereira, Y., Burgain, A., Brient‐Litzler, E., Mezrahi, M., Séguin, J., Manich, M., Popoff, M. R., Scherman, D., & Bigey, P. (2009) · Infection and Immunity · doi:10.1128/iai.01269-08 · Cited by 34
COStar: A D-star Lite-based dynamic search algorithm for codon optimization
Liu, X., Deng, R., Wang, J., & Wang, X. (2013) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2013.11.022 · Cited by 33
Airway CD8+ T cells induced by pulmonary DNA immunization mediate protective anti-viral immunity
Bivas‐Benita, M., Gillard, G. O., Bar, L., White, K., Webby, R. J., Hovav, A.-H., & Letvin, N. L. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.59 · Cited by 33
Lambracht‐Washington, D., Qu, B., Fu, M., Anderson, L. D., Eagar, T. N., Stüve, O., & Rosenberg, R. N. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.09.008 · Cited by 33
DNAVaxDB: the first web-based DNA vaccine database and its data analysis
Racz, R., Li, X., Patel, M., Xiang, Z., & He, Y. O. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-s4-s2 · Cited by 31
Interferon regulatory factor‐1 acts as a powerful adjuvant in tat DNA based vaccination
Castaldello, A., Sgarbanti, M., Marsili, G., Brocca‐Cofano, E., Remoli, A. L., Caputo, A., & Battistini, A. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22169 · Cited by 31
Borggren, M., Nielsen, J. O., Bragstad, K., Karlsson, I., Krog, J. S., Williams, J. A., & Fomsgaard, A. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1011987 · Cited by 30
Chen, Y.-Z., Ruan, G., Yao, X., Li, L., Hu, Y., Tabata, Y., & Gao, J. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-0985-8 · Cited by 29
Self-citationBergamaschi, C., Kulkarni, V., Rosati, M., Alicea, C., Jalah, R., Chen, S., Bear, J., Sardesai, N. Y., Valentin, A., Felber, B. K., et al. (2014) · Gene Therapy · doi:10.1038/gt.2014.84 · Cited by 24
Jiang, W. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.11.076 · Cited by 24
Zuo, Y., Wu, J., Xu, Z., Yang, S., Yan, H., Tan, L., Meng, X., Ying, X., Liu, R., Kang, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019407 · Cited by 24
DNA immunization using a non-viral promoter
Vanniasinkam, T., Reddy, S. T., & Ertl, H. C. J. (2005) · Virology · doi:10.1016/j.virol.2005.08.040 · Cited by 24
Targeting dendritic cells with antigen via dendritic cell-associated promoters
Moulin, V., Morgan, M. E., Eleveld-Trancikova, D., Haanen, J. B. A. G., Wielders, E., Looman, M. W. G., Janssen, R. A. J., Figdor, C. G., Jansen, B., & Adema, G. J. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.2 · Cited by 20
St, W., Chang, C.-C., Yen, M.-C., Cf, T., Chu, C.-L., Yt, P., Dy, C., Jl, L., & Lin, C.-C. (2010) · Gene Therapy · doi:10.1038/gt.2010.146 · Cited by 20
Yu, Y., Ma, Y., Xu, W., Wang, S., & Sun, Z. (2014) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0359-9 · Cited by 17
Chen, H., Gao, N., Wu, J., Zheng, X., Li, J., Fan, D., & An, J. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.08.005 · Cited by 16
Fu, X., Tao, L., & Zhang, X. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.080 · Cited by 15
Shedlock, D. J., Tingey, C., Mahadevan, L., Hutnick, N. A., Reuschel, E. L., Kudchodkar, S. B., Flingai, S., Yan, J. J., Kim, J., Ugen, K. E., et al. (2014) · Vaccines · doi:10.3390/vaccines2020196 · Cited by 13
Geiben-Lynn, R., Frimpong-Boateng, K., & Letvin, N. L. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00390-10 · Cited by 13
Wang, Y., Guo, Y., Wang, X., Huang, J., Shang, J., & Sun, S. (2011) · Gene Therapy · doi:10.1038/gt.2011.67 · Cited by 12
Modulating APOBEC expression enhances DNA vaccine immunogenicity
Almeida, R. R., Raposo, R. A. S., Coirada, F. C., da Silva, J. R., Ferreira, L. C. D. S., Kalil, J. E., Nixon, D. F., & Cunha‐Neto, E. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.53 · Cited by 10
Targeting DNA vaccines to myeloid cells using a small peptide
Ye, C., Choi, J. G., Abraham, S., Shankar, P., & Manjunath, N. (2014) · European Journal of Immunology · doi:10.1002/eji.201445010 · Cited by 8
Plasmids Encoding Protein Aggregation Domains Act As Molecular Adjuvants for DNA Vaccines
Capitani, M., Saadé, F., Havas, K. M., Angeletti, M., Concetti, F., Agas, D., Sabbieti, M. G., Concetti, A., Venanzi, F. M., & Petrovsky, N. (2014) · Current Gene Therapy · doi:10.2174/1566523214666140509114838 · Cited by 8
Self-citationSpatz, S. J., Volkening, J. D., Mullis, R., Li, F., Mercado, J., & Zsak, L. (2013) · Virus Genes · doi:10.1007/s11262-013-0944-9 · Cited by 7
Down-regulation of Prdx6 contributes to DNA vaccine induced vitiligo in mice
Zhou, Q., Wang, F., Zhang, Y., Yang, F., Wang, Y., & Sun, S. (2010) · Molecular BioSystems · doi:10.1039/c0mb00181c · Cited by 6
Enhancement of DNA Vaccine Efficacy by Intracellular Targeting Strategies
Freitas, E. B., Henriques, A. M., Fevereiro, M., Prazeres, D. M. F., & Monteiro, G. A. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0410-5_4 · Cited by 3
Cited by
Neoantigens: promising targets for cancer therapy
Xie, N., Shen, G., Gao, W., Huang, Z., Huang, C., & Fu, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01270-x · Cited by 1,020
New Vaccine Technologies to Combat Outbreak Situations
Rauch, S., Jasny, E., Schmidt, K. E., & Petsch, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01963 · Cited by 579
Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
Lopes, A., Vandermeulen, G., & Préat, V. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1154-7 · Cited by 385
COVID-19 Vaccine Frontrunners and Their Nanotechnology Design
Chung, Y. H., Beiss, V., Fiering, S. N., & Steinmetz, N. F. (2020) · ACS Nano · doi:10.1021/acsnano.0c07197 · Cited by 346
Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review)
Calina, D., Docea, A., Petrakis, D., Egorov, A., Ishmukhametov, A., Gabibov, A., Shtilman, M., Kostoff, R., Carvalho, F., Vinceti, M., et al. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4596 · Cited by 318
Metadata
- Authors
- Li, L., & Petrovsky, N.
- Venue
- Expert Review of Vaccines
- Publisher
- Informa UK Limited
- Published
- 2015-12-28
- Volume
- 15
- Issue
- 3
- Pages
- 313-329
- ISSN
- 1476-0584 (ISSN-L)
- 1744-8395
- OpenAlex
- W2198678042
- Cited by
- 335
- References
- 134
- FWCI
- 4.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.